Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,867 | 86,327 | 94,386 | 95,817 | 157,463 |
| Marketable Securities | N/A | N/A | N/A | 2,501 | 27,480 |
| Receivables | 35,961 | 34,627 | 29,843 | 24,102 | 23,079 |
| Inventories | 46,386 | 39,765 | 36,010 | 46,209 | 21,995 |
| TOTAL | $163,309 | $169,547 | $168,528 | $177,383 | $234,306 |
| Non-Current Assets | |||||
| PPE Net | 46,198 | 48,279 | 47,602 | 50,613 | 50,783 |
| Intangibles | 12,197 | 81,938 | 90,163 | 99,570 | 15,279 |
| Other Non-Current Assets | 48,928 | 49,364 | 41,242 | 38,039 | 30,342 |
| TOTAL | $107,323 | $179,581 | $179,007 | $188,222 | $96,404 |
| Total Assets | $270,632 | $349,128 | $347,535 | $365,605 | $330,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,860 | 9,074 | 7,633 | 8,984 | 3,832 |
| Accrued Expenses | 21,199 | 18,840 | 17,847 | 14,793 | 12,445 |
| Other current liabilities | N/A | N/A | 4,315 | 13,090 | N/A |
| TOTAL | $31,059 | $27,914 | $29,795 | $36,867 | $16,277 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,308 | 29,215 | 20,498 | 44,443 | 21,724 |
| TOTAL | $27,308 | $35,651 | $30,655 | $56,338 | $26,055 |
| Total Liabilities | $58,367 | $63,565 | $60,450 | $93,205 | $42,332 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,850 | 14,633 | 14,467 | 14,330 | 14,168 |
| Common Shares | 147 | 146 | 144 | 143 | 143 |
| Retained earnings | 128,052 | 210,719 | 225,578 | 221,444 | 245,426 |
| Other shareholders' equity | -5,943 | -6,443 | -5,718 | -4,542 | -5,898 |
| TOTAL | $212,265 | $285,563 | $287,085 | $272,400 | $288,378 |
| Total Liabilities And Equity | $270,632 | $349,128 | $347,535 | $365,605 | $330,710 |